Table 1 Characteristics of SLE patients and healthy controls studied
Healthy | SLE subjects | |||
|---|---|---|---|---|
(n= 10) | All (n= 39) | HCQ (n= 25) | No HCQ (n= 14) | |
Age, years (SD) | 30 (4.3)1 | 53 (12.5)1 | 50.4 (12.7) | 57.6 (11.2) |
Female, n (%) | 8 (80%) | 36 (92%) | 22 (88%) | 14 (100%) |
European ancestry, n (%) | 10 (100%) | 39 (100%) | 25 (100%) | 14 (100%) |
Years since SLE diagnosis (SD) | 19.2 (9.7) | 17.2 (9.4) | 22.7 (9.6) | |
SLE activity (SLAQ) | 10.4 (8.4) | 11.8 (8.9) | 8.1 (7.3) | |
Treatment | ||||
prednisone, n (%) | 12 (30.8%) | 9 (36%) | 3 (21.4%) | |
immunosuppressant, n (%) | 8 (20.5) | 5 (20%) | 3 (21.4%) | |